✦ LIBER ✦

Nuclear polymorphism — a prognostic parameter to evaluate local recurrence of female breast cancer

✍ Scribed by H. R. Rosen; M. Stierer; R. Weber

Publisher: Springer US
Year: 1990
Tongue: English
Weight: 320 KB
Volume: 17
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01812679

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast Cancer Local Recurrence: Risk Fac

Breast Cancer Local Recurrence: Risk Factors and Prognostic Relevance of Early Time to Recurrence

✍ A. Neri; D. Marrelli; S. Rossi; A. De Stefano; F. Mariani; G. De Marco; S. Carus 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 89 KB

140 Evaluation of HER-2 neu oncoprotein

140 Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study

✍ Bruce G. Haffty; Felix Brown; Stuart Flynn 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 135 KB

The relative importance of estrogen rece

The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer

✍ Russell Hilf; Michael L. Feldstein; Scott L. Gibson; Edwin D. Savlov 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Immunocytochemical localization of fos p

Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

✍ Julia M. W. Gee; Ian O. Ellis; John F. R. Robertson; Peter Willsher; Richard A. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 805 KB

The nuclear transcription factor Fos is inducible by both steroid hormones and peptide growth factors. It thus forms a potential point of interaction between steroid hormone-and growth factor-directed pathways and may be critical in the subversion of steroid hormone control in breast cancer. In this

Evaluation of OncotypeDX Recurrence Scor

Evaluation of OncotypeDX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer

✍ Kyoko Yorozuya; Toru Takeuchi; Miwa Yoshida; Yukako Mouri; Junko Kousaka; Kimihi 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 288 KB

Immunocytochemical localization of BCL-2

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

✍ Julia M. W. Gee; John F. R. Robertson; Ian O. Ellis; Peter Willsher; Richard A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 824 KB

The protein product of the bcl-2 gene is thought to be involved in inhibition of apoptosis; it may therefore be important in the modulation of hormonal/anti-hormonal responsiveness exhibited by tumours. This study immunocytochemically investigates (i) relationships between bcl-2 protein expression i